Haemagglutinin-strain B

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Indication: Not Available
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings: Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics: Not Available
Mechanism of action: Not Available
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half-life: Not Available
Clearance: Not Available
Adverse Effects: Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity: Not Available
Pathways: Not Available
Pharmacogenomic Effects/ADRs: Not Available

Drug Interactions: This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions: Not Available

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
Agriflu	Haemagglutinin-strain B (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain A(H3N2) (15 mcg)	Suspension	Intramuscular	Seqirus Uk Limited	2010-10-04	2020-06-30
Agriflu	Haemagglutinin-strain B (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL)	Suspension	Intramuscular	Seqirus Uk Limited	2015-10-09	Not applicable
Fluad	Haemagglutinin-strain B (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL)	Suspension	Intramuscular	Seqirus Uk Limited	2011-09-10	Not applicable
Fluad Pediatric	Haemagglutinin-strain B (7.5 mcg / 0.25 mL) + Haemagglutinin-strain A(H1N1) (7.5 mcg / 0.25 mL) + Haemagglutinin-strain A(H3N2) (7.5 mcg / 0.25 mL)	Suspension	Intramuscular	Seqirus Uk Limited	2015-11-05	Not applicable
Fluviral	Haemagglutinin-strain B (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL)	Suspension	Intramuscular	ID Biomedical Corporation of Quebec	1993-12-31	2015-09-23

Clinical Trials

Phase	Status	Purpose	Conditions	Count
4	Active Not Recruiting	Prevention	Adverse Reaction to Vaccine / Elderly Infection / Flu caused by Influenza / Obesity / Pregnancy; Infection / Tolerance / Vaccine Reaction	1
4	Completed	Basic Science	Flu caused by Influenza	2
4	Completed	Basic Science	Flu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections	1
4	Completed	Basic Science	Flu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections / Tuberculosis (TB)	1
4	Completed	Health Services Research	Flu caused by Influenza / Vaccination Site Reactions (HT)	1

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Suspension	Intramuscular
Suspension	Intramuscular; Subcutaneous
Injection, suspension	Intramuscular; Subcutaneous
Suspension	Intradermal
Injection

Prices

Not Available

Patents

Not Available

Drug created at August 30, 2019 17:11 / Updated at June 12, 2020 16:53